An observational study in Cancer, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute). Recruiting at 1 site in United States. Open to participants aged 20 Years to 89 Years. Per ClinicalTrials.gov, last updated 2026-07-08.
Sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · Observational
This protocol seeks to analyze patient outcomes of the standard of care, monitored group exercise regimen of high-load resistance training and functional exercises with compound movements under close supervision on individuals who have been treated for cancer.
10,818 studies on the registry are indexed under Neoplasms; 2,324 are open to participants now.
This study's planned enrollment of 100 is below the median of 200 across 2,638 observational studies indexed under Neoplasms.
Browse Neoplasms studies →Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) is the lead sponsor of 49 studies on the registry; 20 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 4 (44%) have results posted.
Counted across the registry records on this site, refreshed daily.
Individuals diagnosed with cancer on an exercise program at the AHN Exercise Oncology and Resiliency Center
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
1. Severe arthritic, joint, cardiovascular, or musculoskeletal condition that would interfere with exercise program
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Childbearing potential
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
All patients undergoing treatment for cancer on an exercise regimen
Other: Dose escalated resistance training
All patients undergoing treatment for head and neck cancer on an exercise regime
Other: Dose escalated resistance training
All patients undergoing treatment for colorectal cancer on an exercise regime
Other: Dose escalated resistance training
All patients undergoing treatment for pancreatic cancer on an exercise regime
Other: Dose escalated resistance training
All patients undergoing treatment for metastatic breast cancer on an exercise regime
Other: Dose escalated resistance training
All individuals will be engaging in resistance training during and/or after their cancer treatment
Determine changes in fat mass in pounds from before to after the nutrition and exercise regimen via bioimpedance analysis
Measurement on bioimpedance analysis machine (Inbody 970)
Time frame: 3 months
Determine changes in fat mass in pounds from before to after the nutrition and exercise regimen via ultrasound
Measurement via ultrasound and calculation with Jackson-Pollack calculations
Time frame: 3 months
Determine changes in muscle mass in pounds from before to after the nutrition and exercise regimen
Measurement on bioimpedance analysis machine (Inbody 970)
Time frame: 3 months
Determine changes in overall score of functional movement screen (FMS) from before to after the nutrition and exercise regimen
Determine changes in overall score of functional movement screen (FMS) from before to after the nutrition and exercise regimen
Time frame: 3 months
Determine changes in Y-balance score for each leg
Y-balance score adds up the distance each leg can move in the front and side directions, divided by the length of the hip. This correlates inversely with fall risk.
Time frame: 3 months
Determine changes in strength via load measured in pounds from before to after the nutrition and exercise regimen
Load is calculated by multiplying sets by repetitions by weight lifted for a specific exercise
Time frame: 3 months
Determine changes in EQ-5D responses 1-5 and overall score from before to after the nutrition and exercise regimen
EQ-5D asks 5 questions rates from 1-5 and an overall rating of health
Time frame: 3 months
Plan to share: Undecided
Started Feb 2023 (actual). Primary completion is estimated for Jan 2027, 47 months after the start.
Of 1,098 non-industry observational studies under Neoplasms, half reached primary completion within 61 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 227. This study's planned 47 months is below that.
Counting every sponsor, half of 1,246 studies reached it within 58 months; a quarter within 24 and three quarters within 210.
Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)